Estimating Watershed Evapotranspiration with PASS. Part I: Inferring Root-Zone Moisture Conditions Using Satellite Dat

A model framework for parameterized subgrid-scale surface fluxes (PASS) has been modified and applied as PASS1 to use satellite data, models, and limited surface observations to infer root-zone available moisture (RAM) content with high spatial resolution over large terrestrial areas. Data collected during the 1997 Cooperative Atmosphere–Surface Exchange Study field campaign at the Atmospheric Boundary Layer Experiments site in the Walnut River watershed in Kansas were used to evaluate applications of the PASS1 approach to infer soil moisture content at times of satellite overpasses during cloudless conditions. Data from Advanced Very High Resolution Radiometers on the NOAA-14 satellite were collected and then adjusted for atmospheric effects by using LOWTRAN7 and local atmospheric profile data from radiosondes. The input variables for PASS1 consisted of normalized difference vegetation index and surface radiant temperature, together with representative observations of downwelling solar irradiance, air temperature, relative humidity, and wind speed. Surface parameters, including roughness length, albedo, surface conductance for water vapor, and the ratio of soil heat flux to net radiation, were estimated with parameterizations suitable for the area using satellite data and land-use information; pixel-specific near-surface meteorological conditions such as air temperature, vapor pressure, and wind speed were adjusted according to local surface forcing; and RAM content was estimated using surface energy balance and aerodynamic methods. Comparisons with radar cumulative precipitation observations and in situ soil moisture estimates indicated that the spatial and temporal variations of RAM at the times of satellite overpasses were simulated reasonably well by PASS1

Estimating reprocessing plant in-process inventories by simulation

The Safeguards Systems Group`s generic simulation program FacSim was used to model the operation of the proposed Rokkasho Reprocessing Plant during an operating cycle consisting of a start-up phase, a period of steady-state operation, and a flush-out phase. The simulation results give a detailed account of nuclear material inventories in various process vessels as a function of time. As expected, it is found that the pulsed columns and the concentrator determine the rate at which the system responds to feed variations and transients; but the in-process inventory is dominated by the contents of the concentrator and tanks, and particularly by the contents of the tanks downstream from the concentrator. The results of the simulation were used for statistical studies of diversion detection, as described elsewhere in the Proceedings

Clodronate-liposome mediated macrophage depletion abrogates multiple myeloma tumor establishment in vivo

Multiple myeloma is a fatal plasma cell malignancy that is reliant on the bone marrow microenvironment. The bone marrow is comprised of numerous cells of mesenchymal and hemopoietic origin. Of these, macrophages have been implicated to play a role in myeloma disease progression, angiogenesis, and drug resistance; however, the role of macrophages in myeloma disease establishment remains unknown. In this study, the antimyeloma efficacy of clodronate-liposome treatment, which globally and transiently depletes macrophages, was evaluated in the well-established C57BL/KaLwRijHsd murine model of myeloma. Our studies show, for the first time, that clodronate-liposome pretreatment abrogates myeloma tumor development in vivo. Clodronate-liposome administration resulted in depletion of CD169+ bone marrow-resident macrophages. Flow cytometric analysis revealed that clodronate-liposome pretreatment impaired myeloma plasma cell homing and retention within the bone marrow 24 hours postmyeloma plasma cell inoculation. This was attributed in part to decreased levels of macrophage-derived insulin-like growth factor 1. Moreover, a single dose of clodronate-liposome led to a significant reduction in myeloma tumor burden in KaLwRij mice with established disease. Collectively, these findings support a role for CD169-expressing bone marrow-resident macrophages in myeloma disease establishment and progression and demonstrate the potential of targeting macrophages as a therapy for myeloma patients.Khatora S. Opperman, Kate Vandyke, Kimberley C. Clark, Elizabeth A. Coulter, Duncan R. Hewett, Krzysztof M. Mrozik, Nisha Schwarz, Andreas Evdokiou, Peter I Croucher, Peter J Psaltis, Jacqueline E Noll and Andrew CW Zannettin